AJP - Renal  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 288: F207-F213, 2005. First published September 14, 2004; doi:10.1152/ajprenal.00216.2004
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/F207    most recent
00216.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vázquez, E.
Right arrow Articles by Escalante, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez, E.
Right arrow Articles by Escalante, B.

Angiotensin II-dependent induction of AT2 receptor expression after renal ablation

Erika Vázquez,1 Israel Coronel,2 Rocio Bautista,3 Eunice Romo,2 Carlos M. Villalón,1 M. Carmen Avila-Casado,4 Virgilia Soto,4 and Bruno Escalante2

Departments of 1Pharmacobiology and 2Molecular Biomedicine, Centro de Investigación y de Estudios Avenzados de Instituto Politécnico Nacional, Mexico City; 3Pharmacology, Facultad Estudios Supeviores-Iztacala Universidad Nacional Autonoma de Mexico, México City; and 4Pathology, Instituto Nacional de Cardiología "Ignacio Chávez," Mexico City, Mexico

Submitted 10 June 2004 ; accepted in final form 30 August 2004

Angiotensin (ANG) II can be associated with gene expression regulation. Thus we studied the possible role of ANG II in the regulation of AT2 mRNA and protein expression. We utilized sham-operated renal ablation rats as well as renal ablation rats pretreated during the first 7 days of the development of renal damage with either the angiotensin-converting inhibitor ramipril, the AT1 receptor antagonist losartan, or the AT2 receptor antagonist PD-123319. Renal tissue was analyzed for histological changes and expression of AT2 receptor mRNA (by RT-PCR) and protein (by immunohistochemistry). To explore the physiological role of AT2 receptor overexpression in the development of renal damage, blood pressure, urinary protein excretion, and renal damage were evaluated. A time-dependent increase in the expression of AT2 receptor mRNA and protein was observed at 7, 15, and 30 days after renal ablation. Because these effects were already evident at day 7, the effects of ramipril, losartan, or PD-123319 were tested at this time. The ramipril group and the PD-123319-pretreated group showed inhibition of AT2 receptor expression, whereas the losartan-pretreated group showed a further increase in AT2 receptor expression. Inhibition of the AT2 receptor during renal ablation was associated with increased renal damage and a further increase in the blood pressure. This suggests that overexpression of AT2 receptors after renal ablation is modulated by ANG II through its own AT2 receptor and that functional expression of this effect may represent a counterregulatory mechanism to modulate the renal damage induced by renal ablation.

AT1 receptor; renovascular hypertension; losartan; PD-123319



Address for reprint requests and other correspondence: B. Escalante, Dept. of Molecular Biomedicine, CINVESTAV-IPN, Av. Instituto Politécnico Nacional 2508, CP 07360, Mexico City, Mexico (E-mail: bescalan{at}mail.cinvestav.mx)




This article has been cited by other articles:


Home page
J. Physiol.Home page
J. S. Gilbert, A. L. Lang, A. R. Grant, and M. J. Nijland
Maternal nutrient restriction in sheep: hypertension and decreased nephron number in offspring at 9 months of age
J. Physiol., May 15, 2005; 565(1): 137 - 147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.